Health care resource utilization and expenditures associated with the use of insulin glargine

被引:14
作者
Miller, Donald R.
Gardner, John A.
Hendricks, Ann M.
Zhang, Quanwu
Fincke, Benjamin G.
机构
[1] VA Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA
[2] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA
[3] VA Boston Healthcare Syst, Hlth Care Financing & Econ, Jamaica Plain, MA USA
[4] Sanofi Aventis USA, Bridgewater, NJ USA
关键词
diabetes; insulin; delivery of health care; health care costs;
D O I
10.1016/S0149-2918(07)80086-5
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Background: Newer insulins, such as long-acting analogues, offer promise of better glycemic control, reduced risk for diabetes complications, and moderation of health care use and costs. Objective: We studied initiation of insulin glargine to evaluate its association with subsequent health service utilization and estimated expenditures. Methods: Patients of the Veterans Health Administration, US Department of Veterans Affairs (VA) who initiated insulin glargine (n = 5064) in 2001-2002 were compared with patients receiving other insulin (n = 69,944), matched on prescription month (index date). Inpatient and outpatient VA care in the 12 months after a patient's index date was evaluated using Tobit regression, controlling for prior utilization, demographic characteristics, comorbidities, glycosylated hemoglobin (HbA(1c)) levels, and diabetes severity. National average utilization costs and medication acquisition costs were used to estimate the value of VA expenditures. Results: Compared with other insulin users, insulin glargine initiators had higher HbA(1c) values (8.72% vs 8.16%) prior to the index date, but greater subsequent HbA(1c) reduction (-0.50% vs -0.22%). After adjustment for age, prior utilization, HbA(1c) levels, and other factors, insulin glargine initiation was associated with 2.4 (95% CI, 1.1-3.7) fewer inpatient days for patients with any hospital admission (US $820 lower costs per initiator), 1.6 (1.2-1.9) more outpatient encounters ($279 higher costs per initiator), and $374 ($362-$387) higher costs for diabetes medications. The net difference was an average lower VA cost of $166 (-$290 to $622) per patient. Conclusions: Insulin glargine use was associated with decreased inpatient days but increased outpatient care, and the value of the net change in utilization to VA offset the additional medication expenditures. Initiation of insulin glargine improves glycemic control and may reduce time in hospital without additional use of health resources. (Clin Ther. 2007;29:478-487) Copyright (c) 2007 Excerpta Medica, Inc.
引用
收藏
页码:478 / 487
页数:10
相关论文
共 39 条
[1]
VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].
ABRAIRA, C ;
COLWELL, JA ;
NUTTALL, FQ ;
SAWIN, CT ;
NAGEL, NJ ;
COMSTOCK, JP ;
EMANUELE, NV ;
LEVIN, SR ;
HENDERSON, W ;
LEE, HS .
DIABETES CARE, 1995, 18 (08) :1113-1123
[2]
Abraira C, 1999, AM HEART J, V138, pS360
[3]
*AMA, 2000, CURR PROC TERM 2001
[4]
Identifying hypertension-related comorbidities from administrative data: What's the optimal approach? [J].
Borzecki, AM ;
Wong, AT ;
Hickey, EC ;
Ash, AS ;
Berlowitz, DR .
AMERICAN JOURNAL OF MEDICAL QUALITY, 2004, 19 (05) :201-206
[5]
Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207
[6]
Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products [J].
Bullano, MF ;
Al-Zakwani, IS ;
Fisher, MD ;
Menditto, L ;
Willey, VJ .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (02) :291-298
[7]
Using administrative databases for outcomes research: Select examples from VA Health Services Research and Development [J].
Cowper D.C. ;
Hynes D.M. ;
Kubal J.D. ;
Murphy P.A. .
Journal of Medical Systems, 1999, 23 (3) :249-259
[8]
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[9]
2-B
[10]
MORTALITY ASCERTAINMENT IN THE VETERAN POPULATION - ALTERNATIVES TO THE NATIONAL DEATH INDEX [J].
FISHER, SG ;
WEBER, L ;
GOLDBERG, J ;
DAVIS, F .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (03) :242-250